SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Turner BJ, McKee L, Fanning T, Markson LE. AIDS specialist versus generalist ambulatory care for advanced HIV infection and impact on hospital use. Med Care. 1994;32: 90216.
  • 2
    Markson LE, Cosler LE, Turner BJ. Implications of generalists' slow adoption of zidovudine in clinical practice. Arch Intern Med. 1994;154: 1497504.
  • 3
    Kitahata MM, Koepsell TD, Deyo RA, Maxwell CL, Dodge WT, Wagner EH. Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival. N Engl J Med. 1996;334: 7016.
  • 4
    Hayward RA, Kravitz RL, Shapiro MF. Program directors' attitudes towards residents' care of patients who have AIDS. J Gen Intern Med. 1991;6: 1826.
  • 5
    Hayward RA & Weissfeld JL. Coming to terms with the era of AIDS: attitudes of physicians in U.S. residency programs. J Gen Intern Med. 1993;8: 108.
  • 6
    Shapiro MF, Hayward RA, Guillemot D, Jayle D. Residents' experiences in, and attitudes toward, the care of persons with AIDS in Canada, France, and the United States. JAMA. 1992;268: 5105.
  • 7
    Wu AW. A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection. Med Care. 1991;29: 78698.
  • 8
    Revicki DA, Sorensen S, Wu AW. Reliability and validity of physical and mental health summary scores from the Medical Outcomes Study HIV Health Survey. Med Care. 1998;36: 12637.
  • 9
    Anonymous. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus. Morb Mortal Wkly Rep. 1992;41(RR-4):111.
  • 10
    Anonymous. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS/IDSA Prevention of Opportunistic Infections Working Group. Clin Infect Dis. 1997;25(Suppl 3):3135.
  • 11
    Anonymous. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS/IDSA Prevention of Opportunistic Infections Working Group. Clin Infect Dis. 1995;21(Suppl 1):3243.
  • 12
    Anonymous. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. Ann Intern Med. 1997;127: 92246.
  • 13
    Gebo KA, Chaisson RE, Folkemer JG, Bartlett JG, Moore RD. Costs of HIV medical care in the era of highly active antiretroviral therapy. AIDS. 1999;13: 9639.
  • 14
    Mouton Y, Alfandari S, Valette M, et al. Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. Federation National des Centres de Lutte contre le SIDA. AIDS. 1997;11: F101F105.
  • 15
    Torres RA & Barr M. Impact of combination therapy for HIV infection on inpatient census [letter]. N Engl J Med. 1997;336: 15312.
  • 16
    Bozzette SA, Berry SH, Duan N, et al. The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. N Engl J Med. 1998;339: 1897904.
  • 17
    Shapiro MF, Morton SC, McCaffrey DF, et al. Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. JAMA. 1999;281: 230515.